Drug details:
Molecular formula: C₂₂H₂₃N₃O

Standard name: (3S)-3-amino-4-(1H-imidazol-5-yl)-1-[4-[(E)-2-(4-methylphenyl)ethenyl]phenyl]butan-2-one

Curated SMILES: CC1=CC=C(C=C1)/C=C/C2=CC=C(C=C2)CC(=O)[C@H](CC3=CN=CN3)N

Evidence for compound's anti-virulence activity:

Brucella
Related VFcategory: Others
Target: Histidinol dehydrogenase (HDH)
Drug effect: Inhibits HDH activity to interfere with histidine biosynthesis which is essential for intramacrophagic replication.
Max phase: Preclinical (in vitro)
Publication:
Abdo MR, et al., 2011. Anti-virulence strategy against Brucella suis: synthesis, biological evaluation and molecular modeling of selective histidinol dehydrogenase inhibitors. Org Biomol Chem 9(10):3681-90.